Related Experiment Videos
Activation of the terminal complement cascade in renal infarction
1Department of Bacteriology and Immunology, University of Helsinki, Finland.
Kidney International
|March 1, 1995
Summary
The complement system plays a key role in kidney damage from ischemia. This study found complement deposits in human renal infarction lesions, particularly in proximal tubules, suggesting its involvement in the injury process.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Ischemic injury significantly impairs kidney function.
- The complement system is implicated in ischemic tissue damage, notably in myocardial infarction.
Purpose of the Study:
- To investigate the role of the complement system in renal ischemic lesions.
- To determine the deposition and distribution of complement components and regulators in human renal infarction.
Main Methods:
- Indirect immunofluorescence microscopy was used to study human renal infarction lesions.
- Complement components (C1q, C3c, C3d, C4, C5, C6, C9) and regulators (vitronectin, clusterin, protectin/CD59) were analyzed.
- Tubular segment markers (Tamm-Horsfall glycoprotein, brush border antigens) localized deposits.
Main Results:
- Terminal complement complex (TCC) components, vitronectin, and clusterin were deposited in infarcted areas, especially on tubular epithelial cells and in lumina.
- TCC deposits were predominantly found in proximal tubules and formed crescent-like patterns in glomeruli.
- Expression of protectin (CD59) was reduced in tubular epithelial cells within infarction lesions.
- In vitro experiments showed TCC generation upon contact of human serum with urine.
Conclusions:
- The complement system is involved in the pathogenesis of human renal infarction.
- Complement activation may be initiated by interactions between serum and urine.
- Findings highlight the potential for complement-targeted therapies in renal ischemia.